Status:
COMPLETED
Assessing the Effects of the Muse Sleep Intervention on Sleep
Lead Sponsor:
Western University, Canada
Collaborating Sponsors:
InteraXon, Inc.
Cambridge Brain Sciences
Conditions:
Mediation
Coaching
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
In this study, we will examine whether use of the Sleep Intervention protocol marketed by Interaxon (the 'Muse'), leads to improvements in sleep quality (e.g. decreased latency to sleep, improved slee...
Detailed Description
We all sleep, hopefully, every single day. Regular and sufficient sleep helps maintain numerous aspects of physical and mental health, but countless ordinary life circumstances, such as parenthood, de...
Eligibility Criteria
Inclusion
- The study will be open to all Hatch employees in Canada. Hatch is a large engineering firm in Canada. Hatch currently has 4406 Canadian employees and therefore our sample size represents approximately 10% of the population.
Exclusion
- None
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04863690
Start Date
May 1 2021
End Date
December 1 2022
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western University
London, Canada